Emerging Dolutegravir Resistance Among Children on Antiretroviral Therapy With Virological Failure in Malawi: Results From a 2023 National Cross-Sectional Survey

By afschroeder • May 23, 2026

Bello G, Kabaghe AN, Pals S, Kalata NL, Bighignoli B, van Oosterhout JJ, Mkungudza J, Agyemang E, Zheng DP, Panja L, Matola WB, Chitenje M, Kampira E, Zeh C, Mvula B, Alvarez B, Kagoli M, Mzumara W, Simon KR, Namakhoma I, O'Malley G, Chipeta S, Nyirenda R, da Silva J, Wadonda N; For Malawi HIV Drug Resistance Surveillance Team. Emerging Dolutegravir Resistance Among Children on Antiretroviral Therapy With Virological Failure in Malawi: Results From a 2023 National Cross-Sectional Survey. J Int AIDS Soc. 2026 May;29(5):e70108. doi: 10.1002/jia2.70108. PMID: 42175669.

Tags: children living with HIV, dolutegravir, Infectious Diseases, Malawi, paediatric HIV drug resistance, prevalence, Publications, treatment failure

Th2 skewing in patients with disseminated coccidioidomycosis

Thauland TJ, Nagarajan SS, Stephens AV, Jensen SL, Srivastava A, Moreno Lastre MA, Ahn TS, Bun C, Trump MT, Johnson RH, Thompson GR 3rd, Garcia-Lloret[...]

Shared anti-biofilm targets of biofilm regulators Wor3 and Bcr1 in Candida albicans

Goerlich K, Solis NV, Filler SG, Mitchell AP. Shared anti-biofilm targets of biofilm regulators Wor3 and Bcr1 in Candida albicans. Genetics. 2026 May 22:iyag129. doi:[...]

Rapid Cas13a-based pen A genotyping for cefixime susceptibility in Neisseria gonorrhoeae

Nguyen THY, Garg S, Adams G, Mantena S, Gopal N, Suk H-J, D Klausner J, Sabeti PC, Lemieux JE, Allan-Blitz L-T. Rapid Cas13a-based penA genotyping for[...]